PGEN
PrecigenCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
Primary-source evidence improved versus the prior baseline: PAPZIMEOS is approved, Q4 2025 included the first partial quarter of US sales, management described stronger Q1 2026 demand, broad payer access, and a permanent J-code effective April 1, 2026, which together support a real commercialization path [#PR-2026-03-25].
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -6.1.
What can break
Balance-sheet risk remains material for a small biopharma: the 10-K shows $100.0 million of long-term debt and an operating loss in 2025, so weaker uptake could reopen financing concerns [#10-K-2026-03-25].
Momentum
86
Value
41
Sentiment
36
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $4.40 · Bull $7.50 · Bear $2.10
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $12.50
Why
Momentum86 · Δ7d -6.1
Value41 · Δ7d +0.0
Sentiment36 · Δ7d +3.4
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
86
26% active weight
Current posture
7d trendSoftening
Δ7d
-6.1
Δ21d
-3.6
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
36
34% active weight
Current posture
7d trendImproving
Δ7d
+3.4
Δ21d
+12.4
Why this grade
Composite grade C. Momentum 86.4 / Value 41.1 / Sentiment 36.5
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$1.76B
Beta
1.07
Shares Out
356.51M
P/E (TTM) · Derived
-3.6
P/S (TTM)
234.42
P/FCF (TTM) · Derived
-13.98
Rev YoY
+1633.9%
EPS YoY
-87.8%
Gross Margin
+76.1%
Op Margin
-1860.2%
Net Debt
$432K
Current Ratio
4.82
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology